Xanthine Oxidase Inhibitors Market to Garner Brimming Revenues by 2018 to 2028
Xanthine oxidase inhibitors inhibit the activity of the enzyme xanthine oxidase. The enzyme xanthine oxidase is involved in the metabolism of nucleotide purine and the production of uric acid. Xanthine oxidase converts hypoxanthine to xanthine and xanthine to uric acid. Several xanthine oxidase inhibitors are available in the market to treat hyperuricemia and other related disorders such as gout. The main causes of hyperuricemia in blood are either the overproduction of uric acid by the body or the underexcretion of...
View full press release